The fund invests primarily in Australian listed companies included in the S&P/ASX 300 Index at the time of investment and will also have some exposure to cash.
| Value | $46.8M NZD |
| Period of data report | 31st Dec. 2024 |
| Fund started | 10th July 2024 |
| Total annual fund fees | 0.98% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 0.98% |
| Other management and administration charges | 0.0% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Mark Arnold |
Currently: Chief Investment Officer - Hyperion Asset Management Limited (17 years, 8 months)
|
|
Jason Orthman |
Currently: Deputy-Chief Investment Officer - Hyperion Asset Management Limited (7 years, 1 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Xero Limited Ordinary Fully Paid
New Zealand Australasian Equities
Block Inc Cdi
United States International Equities
Wisetech Global Limited Ordinary Fully Paid Deferred Settlem
Australia Australasian Equities
Fisher & Paykel Healthcare
New Zealand Australasian Equities
Cochlear Limited
Australia Australasian Equities
CSL Limited
Australia Australasian Equities
Macquarie Group Ltd
Australia Australasian Equities
Resmed Inc
Australia Australasian Equities
Technology One Limited
Australia Australasian Equities
Guzman Y Gomez Ord Shs
Australia Australasian Equities
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 3.65% |
| New Zealand Fixed Interest | 0.0% | 0.0% |
| International Fixed Interest | 0.0% | 0.0% |
| Australasian Equities | 100.0% | 78.29% |
| International Equities | 0.0% | 15.76% |
| Listed Properties | 0.0% | 2.3% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
This data is compiled by Mindful Money from the fund information and portfolios
that each
fund has
filed with the Disclose register to 30th Sept. 2024 and Mindful Money
analysis of funds within those portfolios. The list of companies of concern has
been drawn from ratings agencies and public sources, including the Norwegian
Sovereign Fund, NZ Super Fund, Sustainalytics and research organisations.
Please note that companies may breach more than one of these areas of
concern.
The listing of companies of concern is based on definitions used in Mindful Money's
methodology. These definitions may
be different from the exclusions policy and definitions applied by the fund provider.
Mindful Money uses the term Mindful Funds as our standard
for ethical investment and responsible investment. This does not imply that
other funds are unethical or that the fund providers that do not meet these
standards are unethical providers.
The fund invests primarily in Australian listed companies included in the S&P/ASX 300 Index at the time of investment and will also have some exposure to cash.
| Value | $46.8M NZD |
| Period of data report | 31st Dec. 2024 |
| Fund started | 10th July 2024 |
| Total annual fund fees | 0.98% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 0.98% |
| Other management and administration charges | 0.0% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Mark Arnold |
Currently: Chief Investment Officer - Hyperion Asset Management Limited (17 years, 8 months)
|
|
Jason Orthman |
Currently: Deputy-Chief Investment Officer - Hyperion Asset Management Limited (7 years, 1 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Xero Limited Ordinary Fully Paid
New Zealand Australasian Equities
Block Inc Cdi
United States International Equities
Wisetech Global Limited Ordinary Fully Paid Deferred Settlem
Australia Australasian Equities
Fisher & Paykel Healthcare
New Zealand Australasian Equities
Cochlear Limited
Australia Australasian Equities
CSL Limited
Australia Australasian Equities
Macquarie Group Ltd
Australia Australasian Equities
Resmed Inc
Australia Australasian Equities
Technology One Limited
Australia Australasian Equities
Guzman Y Gomez Ord Shs
Australia Australasian Equities
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 3.65% |
| New Zealand Fixed Interest | 0.0% | 0.0% |
| International Fixed Interest | 0.0% | 0.0% |
| Australasian Equities | 100.0% | 78.29% |
| International Equities | 0.0% | 15.76% |
| Listed Properties | 0.0% | 2.3% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
